fulvestrant has been researched along with oligonucleotides in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Janne, OA; Palvimo, JJ; Poukka, H; Safe, S; Samudio, I; Saville, B; Stoner, M; Wormke, M | 1 |
Huuskonen, J; Nuutinen, T; Ojala, J; Salminen, A; Suuronen, T; Thornell, A | 1 |
Fan, M; Long, X; Nephew, KP | 1 |
3 other study(ies) available for fulvestrant and oligonucleotides
Article | Year |
---|---|
Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein.
Topics: Blotting, Western; Breast Neoplasms; Chromatin; Cloning, Molecular; DNA-Binding Proteins; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor Modulators; Estrogens; Fulvestrant; Gene Deletion; Ligands; Luciferases; Models, Biological; Mutation; Nuclear Proteins; Nuclear Receptor Coactivator 2; Oligonucleotides; Peptides; Precipitin Tests; Protein Binding; Protein Structure, Secondary; Receptors, Estrogen; Response Elements; TATA-Box Binding Protein; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured; Two-Hybrid System Techniques; Zinc Fingers | 2002 |
Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; Blotting, Northern; Cell Proliferation; Cells, Cultured; CpG Islands; DNA; Dose-Response Relationship, Drug; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Estradiol; Fulvestrant; Hippocampus; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Inflammation; Interleukin-6; L-Lactate Dehydrogenase; Lipopolysaccharides; Mice; Microglia; Nitric Oxide; Oligonucleotides; Protein Binding; Raloxifene Hydrochloride; Rats; Rats, Wistar; RNA, Messenger; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors | 2005 |
Estrogen receptor-alpha-interacting cytokeratins potentiate the antiestrogenic activity of fulvestrant.
Topics: Breast Neoplasms; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Keratins; Oligonucleotides; Proteasome Endopeptidase Complex; Receptors, Estrogen; Tamoxifen | 2010 |